What is the official website of Sandoz Romania ?

The official website of Sandoz Romania is https://www.sandoz.ro/.

What is Sandoz Romania's cybersecurity risk score?

Sandoz Romania has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Romania experienced?

According to Rankiteo, Sandoz Romania currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Romania been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Romania has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Romania have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Romania is not certified under SOC 2 Type 1.

Does Sandoz Romania have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Romania does not hold a SOC 2 Type 2 certification.

Does Sandoz Romania comply with GDPR ?

According to Rankiteo, Sandoz Romania is not listed as GDPR compliant.

Does Sandoz Romania have PCI DSS certification ?

According to Rankiteo, Sandoz Romania does not currently maintain PCI DSS compliance.

Does Sandoz Romania comply with HIPAA ?

According to Rankiteo, Sandoz Romania is not compliant with HIPAA regulations.

Does Sandoz Romania have ISO 27001 certification ?

According to Rankiteo,Sandoz Romania is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Romania operate in ?

Sandoz Romania operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Romania have ?

Sandoz Romania employs approximately 59 people worldwide.

Does Sandoz Romania own any subsidiaries ?

Sandoz Romania presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Romania have ?

Sandoz Romania's official LinkedIn profile has approximately 3,532 followers.

What is the NAICS classification code for Sandoz Romania ?

Sandoz Romania is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Romania have a Crunchbase profile ?

No, Sandoz Romania does not have a profile on Crunchbase.

Does Sandoz Romania have a LinkedIn profile ?

Yes, Sandoz Romania maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-romania.

How many cybersecurity incidents has Sandoz Romania experienced ?

As of June 11, 2026, Rankiteo reports that Sandoz Romania has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Romania have ?

Sandoz Romania has an estimated 5,685 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Romania

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Sandoz Romania Vendor Cyber Rating & Cyber Score

sandoz.ro

Add Your Compliance Badge

...

Sandoz Romania A.I CyberSecurity Scoring

Scoring History

Sandoz Romania

Sandoz Romania CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Romania Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Romania

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Romania in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Romania in 2026.

Incident Types Sandoz Romania vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Romania in 2026.

Incident History - Sandoz Romania (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Romania Subsidiaries

Sandoz Romania

Pharmaceutical Manufacturing

Website: https://www.sandoz.ro/

Company Size: 201-500 employees

SandozPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz CanadaPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Loading…

Sandoz Romania Similar Companies

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Loading…

NEWS

Sandoz Romania CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 10, 2021 08:00 AM

Novartis appoints new Country President for its operations in Romania

Swiss pharmaceutical group Novartis has appointed Thodoris Dimopoulos as Country President of its operations in Romania.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53465

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to version 7.1.2-25, a crafted multi-frame can result in a heap buffer over-write when encoding it with the SF3 encoder. This issue has been patched in version 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 6.2)

cvss3

Base Score: 6.2

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.5

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-44cp-c3ww-9rv5

CVE-2026-53464

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to version 7.1.2-25, when providing invalid options to the wand option parser a small memory leak will occur. This issue has been patched in version 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 4)

cvss3

Base Score: 4.0

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.5

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-j989-f892-2335

CVE-2026-53463

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, when passing incorrect arguments in the distort operation a null pointer deference will occur. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-p9rq-q46c-g4x6

CVE-2026-53462

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, when an allocation fails in CheckPrimitiveExtent this can result in a heap-use-after-free and result in a crash. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.2

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-px7q-ggqj-hcf2

CVE-2026-53461

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, an incorrect loop in the ICON decoder can result in an out of bounds heap write resulting in a crash. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-g22q-f7gc-5jhr

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…